Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
ScandiEdge Therapeutics AB
AB
Active
Org 5591320121
Högbergsgatan 39, 118 26
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 8 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ScandiEdge Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
CF
Carl Fredrik Niring
Chief Auditor
Chief Auditor
2025
JN
Johan Nils Otto Järte
Chief Executive Officer
Chief Executive Officer
2025
Former (1)
KM
Karin Marianne Hansson
Chief Executive Officer
Chief Executive Officer
2022 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
BD
Bülent Denkdemir
Board of Directors
Board of Directors
2025
JO
Jan Olof Sölve Borén
Board of Directors
Board of Directors
2022
ED
Elin Desirée Almstedt
Board of Directors
Board of Directors
2025
CE
Carl Erik Mathias Uhlén
Chairman
Chairman
2022
AM
Adil Mardinoglu
Board of Directors
Board of Directors
2022
DB
David Bernhard Sonnek
Deputy Board Member
Deputy Board Member
2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ScandiEdge Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network